Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Shape Therapeutics
Pharma
Otsuka, Astellas, Exelixis and Insilico—Fierce Pharma Asia
Otsuka penned an eye disease gene therapy deal. Astellas will build a new plant in Ireland. Insilico out-licensed an AI-discovered drug to Exelixis.
Angus Liu
Sep 15, 2023 9:00am
'The Top Line': The Fierce 15, Fierce Biotech Summit highlights
Sep 30, 2022 6:00am
ShapeTX claims breakthrough in tissue-specific gene therapies
Dec 8, 2020 9:55am
